Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study

SHUNSUKE TATSUKI, TADAHIRO SHOJI, MARINA ABE, HIDETOSHI TOMABECHI, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, TAKESHI AIDA and TSUKASA BABA
Anticancer Research September 2022, 42 (9) 4603-4610; DOI: https://doi.org/10.21873/anticanres.15964
SHUNSUKE TATSUKI
1Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TADAHIRO SHOJI
1Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tshoji{at}iwate-med.ac.jp
MARINA ABE
1Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDETOSHI TOMABECHI
1Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ERIKO TAKATORI
1Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHITAKA KAIDO
1Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAYUKI NAGASAWA
1Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAHIRO KAGABU
1Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKESHI AIDA
2Department of Obstetrics and Gynecology, Hachinohe Red Cross Hospital, Aomori, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TSUKASA BABA
1Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. 9 4603-4610
DOI 
https://doi.org/10.21873/anticanres.15964
PMID 
36039449

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 14, 2022
  • Revision received July 19, 2022
  • Accepted July 25, 2022
  • Published online August 23, 2022.

Copyright & Usage 
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. SHUNSUKE TATSUKI1,
  2. TADAHIRO SHOJI1⇑,
  3. MARINA ABE1,
  4. HIDETOSHI TOMABECHI1,
  5. ERIKO TAKATORI1,
  6. YOSHITAKA KAIDO1,
  7. TAKAYUKI NAGASAWA1,
  8. MASAHIRO KAGABU1,
  9. TAKESHI AIDA2 and
  10. TSUKASA BABA1
  1. 1Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan;
  2. 2Department of Obstetrics and Gynecology, Hachinohe Red Cross Hospital, Aomori, Japan
  1. Correspondence to: Tadahiro Shoji, Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, 2-1-1 Idaidori, Yahaba Iwate 028-3695, Japan. Tel: +81 196137111, Fax: +81 196131900, e-mail: tshoji{at}iwate-med.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 10 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 42 (9)
Anticancer Research
Vol. 42, Issue 9
September 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 10 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study
SHUNSUKE TATSUKI, TADAHIRO SHOJI, MARINA ABE, HIDETOSHI TOMABECHI, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, TAKESHI AIDA, TSUKASA BABA
Anticancer Research Sep 2022, 42 (9) 4603-4610; DOI: 10.21873/anticanres.15964

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study
SHUNSUKE TATSUKI, TADAHIRO SHOJI, MARINA ABE, HIDETOSHI TOMABECHI, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, TAKESHI AIDA, TSUKASA BABA
Anticancer Research Sep 2022, 42 (9) 4603-4610; DOI: 10.21873/anticanres.15964
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • New frontiers in the management of recurrent epithelial ovarian cancer: a comprehensive review
  • Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
  • Google Scholar

More in this TOC Section

  • Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort
  • Unfavorable Outcomes of T3N0 Remnant Gastric Cancer After Distal Gastrectomy
  • Circulating Tumor DNA Methylation Level Is a More Accurate Prognostic Biomarker in Colon Cancer
Show more Clinical Studies

Keywords

  • ovarian cancer
  • platinum-resistant recurrence
  • chemotherapy
  • platinum rechallenge therapy
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire